Ignite Creation Date:
2024-05-05 @ 9:40 PM
Last Modification Date:
2024-10-26 @ 10:07 AM
Study NCT ID:
NCT00934856
Status:
COMPLETED
Last Update Posted:
2017-04-06
First Post:
2009-07-06
Brief Title:
A Study of Trastuzumab Emtansine T-DM1 in Combination With Docetaxel and Potentially Pertuzumab in Participants With Advanced Breast Cancer
Sponsor:
Organization:
Hoffmann-La Roche